Literature DB >> 18607406

How effective is eltrombopag for the treatment of thrombocytopenia in patients with HCV infection?

James B Bussel1, Kristen M Marks.   

Abstract

Entities:  

Year:  2008        PMID： 18607406     DOI： 10.1038/ncpgasthep1185

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN： 1743-4378


× No keyword cloud information.
  2 in total

1.  Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia.

Authors:  Bing Li; Ying Jie Ji; Qing Shao; Zhenyu Zhu; Dong Ji; Fan Li; Guofeng Chen
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

Review 2.  Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.

Authors:  Lucy Cook; Nichola Cooper
Journal:  Drug Des Devel Ther       Date:  2010-07-21       Impact factor: 4.162
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.